A Trail of Second-line Chemotherapy Sequential NKG2D CAR-NK Cell Therapy for Pancreatic Cancer
NCT06503497
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
RECRUITING
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Pancreatic Cancer Non-resectable
Interventions
BIOLOGICAL:
chemotherapy sequential CAR-NK cell infusion
Sponsor
Zhejiang University